ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Informatics

Kebotix raises funds for R&D automation

by Rick Mullin
April 24, 2020 | APPEARED IN VOLUME 98, ISSUE 16

 

Kebotix, a start-up developing a materials discovery technology platform that combines artificial intelligence and robotics, has received $11.4 million in funding from the life sciences investment firm Novo Holdings. Among its partnerships, Kebotix is working with Northeastern University to discover materials for photodynamic cancer therapies with support from a $750,000 grant from the Massachusetts Life Sciences Center. The firm, one of C&EN’s 10 Start-Ups to Watch in 2019, secured $5 million in seed funding in 2018.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment